SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " using " 4,490 found 🔀 AI-powered Shuffle
CD Projekt is rebranding as CD Projekt Red, but confusingly, CD Projekt Red is still CD Projekt Red
CD Projekt has rebranded itself as CD Projekt Red – or CD Projekt Red Spółka Akcyjna, to be precise.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
Entertainment Firms Face AI Copyright Uncertainty
Editorial analysis: For AI and ML practitioners, unclear copyright rules raise the legal risk and compliance cost of using generative models in production content pipelines. According to The Economic Times, Indian entertainment firms are investing heavily in AI for content creation, but current copyright law, which is tied to human creativity, may not clearly protect AI-assisted or AI-generated works. The Economic Times reports lawyers warn that, without specific legislation or case law, such works face risks of duplication and misuse, complicating licensing, attribution, and monetization for studios and creators. The article highlights that creators and rights holders in India currently have limited legal recourse under existing statutes, per The Economic Times.
AI As Conscious As That Toy Bird Is Thirsty
OpenAI and the like are using our fantasies about technology to bilk investors, if we want to protect the public we need to establish the difference consciousness and something mimicking it
Assemblyman David Tangipa says California should spend more on veterans than undocumented immigrants
California Assemblyman David Tangipa shared his views on the state's budget negotiations, focusing on tax increases, spending priorities, and the implications of California's $350 billion budget.
I started using Projects in Google Drive; it instantly boosted my productivity
Google Drive finally feels smarter
'All INdiana Politics'
U.S. Sen. Todd Young has said that a proposed $300 billion payment to Iran would not be funded by American taxpayers, and that any ceasefire with Iran must be contingent on the dismantlement of its nuclear program, while Indiana Senators Young and Banks have split on a housing bill now awaiting President Trump's signature.
Austria lobbies EU to host Anthropic AI after US curbs, Bloomberg News reports
Austria is pushing the European Union to consider hosting Anthropic AI system within its borders to counter efforts by the U.S. to block foreigners from using the company's most advanced models, Bloomberg News reported on Sunday.
My 2 sons moved back in with me; my expenses have gone up
My two sons still live with me so they can save on housing costs. That means my expenses have gone up, like electricity and grocery budgets.
Science & Medicine: Scanning the brain to improve treatment for traumatized teens
Around 20% of teens who have experienced emotional trauma don't respond to talk therapy. UT Health San Antonio is using neuroimaging to track brain changes in traumatized teens during a course of therapy to see if they can figure out why, which could lead to the development of more personalized treatments that will help more teens heal.
Hurricanes Acquire Rights to John Carlson
It had been a long day. Some teams were using all of their allotted time, even in the later rounds to make their draft decisions. Then came Carolina, and time had expired while the world waited for them to make pick number 192 in the Draft. What happened? Eric Tulsky and company smacked everyone in […]
AI Is Helping Small Businesses Get More Done, But It’s Far From The Only Productivity-Booster Helping Them Expand
Getting more done in less time is easier than ever for solopreneurs and small business owners, thanks to the ease of hiring contractors, using QR codes, touchless technology and other affordable methods.
Porsche Cayman GT4 Race Car Replaced By New 911 GT4 Race Car Based On The 911 GT3, Which Won't Be Confusing
Porsche racing aficionados will note that, believe it or not, this is the first time Porsche has built a GT4 car out of the 911.
Bill Maher reveals to JD Vance which political party keeps refusing to face his questions
Bill Maher told Vice President JD Vance on Friday's episode of "Real Time" that many of the Democrats he has supported over the years have declined invitations to appear on his show. (Credit: Real Time with Bill Maher)
Week in Politics: Trump and bipartisan housing bill, John Bolton; Democratic socialists
President Trump canceled a signing for major housing legislation, former National Security Advisor John Bolton pled guilty to mishandling classified documents, and Democratic Socialists made gains.
Supreme Court ruling on Roundup points to a confusing difference between the law and science
The Supreme Court’s ruling on Roundup shows science and law use the same word — causation — while asking different questions, writes epidemiologist.
Fallout from USMNT loss to Turkey and previewing the Mbappe-Haaland clash
On today’s show, we look back at the United States’ final group stage match against Turkey and evaluate their readiness for the Round of 32. Manchester City insider Sam Lee joins us to preview the tournament’s first true superstar heavyweight clash as Kylian Mbappe and France square off against Erling Haaland and Norway in a battle for Group I supremacy. Plus, The Athletic’s Jay Harris is back in the studio to break down the latest bracketology, advancement percentages, and qualification permutations for Groups G, H, and I using The Athletic’s World Cup Tracker.
Trump refuses to sign housing bill, says GOP remains ‘well-unified’
‘Pineapple Days’ sidewalk sale draws business to Lincoln stores amid downtown construction
Cinnamon Dokken, owner of A Novel Idea Bookstore, said it was named for the Lemon Days sidewalk sales that many businesses around Lincoln used to do, instead using pineapples.
OHS disbanded, $25 minimum wage push, housing grants: CT Politics news
Plus: A $25 minimum wage push, housing grants for small towns, free bus fares for July 4th, and an online forum with Lamont and Elliott.
‘It’s a bad time to be a normal’: House Republican on current political environment
Rep. Dusty Johnson (R-S.D.) reacts to President Trump's decision to cancel the signing of the bipartisan housing affordability bill. Rep. Johnson also discusses the president’s Iran strategy and the current political environment.
From Linchpin to Lever — Part 1: Measuring Trust in Public Health
Learn how local health departments can measure public trust using existing public health tools to strengthen relationships and improve community health outcomes.
Texas Tech's Red Raider Meats Has Steak Down to a Science
The Lubbock university is training the next generation of agriculture scientists using revenue from selling some of the state's best beef
The Venezuela Earthquakes Hit a Health System Already in Crisis
Firefighters are using cellphone lights because of a flashlight shortage, and an overwhelmed hospital in the disaster zone is operating without running water, one doctor said.
‘Snapdragon 8 Elite Gen 6 Pro’ needed more words to prove its power, three other flagship chips coming
Qualcomm’s Snapdragon chipset lineup is eternally confusing, with slight variations generating new names and options that aren’t all that different....
Warren Buffett Bought A Business For $1.7B ‘Over The Phone Without Ever Meeting The People There’ Using The ‘Most Valuable Skill’ He Learned
Buying a company for $1.7 billion without meeting management sounds like the kind of decision that would keep lawyers busy for months. Warren Buffett did it over the phone. Speaking at the University of Nebraska-Lincoln in 2003, Berkshire Hathaway Chair...
Sweden and WHO launch new long-term initiative to transform Ukraine’s health system
WHO and the Swedish International Development Cooperation Agency (Sida) have launched a new multi-year cooperation project to support the long-term recovery and transformation of Ukraine’s health system. The new project, “Ukraine’s Health System Transformation Initiative: Strengthening Health Governance, Health Financing and Service Delivery for Long-Term Recovery”, was launched at the Ukraine Recovery Conference 2026 in Gdansk, Poland on 26 June, and will run from June 2026 to 2029. Sweden will contribute approximately US$ 26 million (240 million Swedish krona) to support this project. This contribution forms part of Sweden’s broader support to Ukraine through the Team Europe approach, which brings together the European Union, its Member States, and key partners such as the European Commission’s Directorate-General for Enlargement and Eastern Neighbourhood and Enabel, and WHO as lead health agency, to support Ukraine’s recovery, reform agenda and European integration.“Ukraine’s health recovery cannot be measured only by what is rebuilt, but by whether people can count on the health system when they need it most. The scale of the task is immense, with health reconstruction and modernization needs estimated at US$ 19.4 billion over the next decade. Sweden’s US$ 26 million contribution to Ukraine’s Health System Transformation Initiative is a timely investment in the institutions, financing and services that will support Ukraine’s long-term recovery and European integration. WHO remains a trusted partner of the Government of Ukraine in advancing this process. I am deeply grateful to Sweden for its consistent support and partnership,” said Dr Hans Henri P. Kluge, WHO Regional Director for Europe. More than 4 years of war have placed unprecedented pressure on Ukraine’s health system, creating 3 interconnected challenges. The first is responding to the immediate consequences of the war and the urgent health needs of the population. The second is recovering and modernizing health services today. The third is continuing reforms and aligning the health system with European standards in the context of Ukraine’s future accession to the European Union. The war has led to large-scale population displacement, an increasing need for trauma care and rehabilitation, and shortages of health workers. High out-of-pocket payments in Ukraine make access to health services more difficult. Around 46% of total health expenditure is paid directly by individuals, placing a significant financial burden on many households and underscoring the need for reforms in health financing. Older people, persons with disabilities, women, children and veterans continue to face the greatest difficulties in accessing health services. “Ukraine is demonstrating that health system transformation can continue even during war. Ukraine is also continuing to align its health system with European norms and standards. WHO is committed to supporting Ukraine on this journey. We provide technical support, help coordinate partners’ efforts and support the institutional changes needed to strengthen the system. We are grateful to Sweden for its support. Through this partnership, we can help Ukraine build a more resilient, accessible and people-centred health system,” said Dr Jarno Habicht, WHO Representative in Ukraine. About the Health System Transformation InitiativeThe new initiative will support Ukraine through 3 interconnected areas: strengthening governance and coordination of health sector reforms through more inclusive coordination platforms and structured policy dialogue; transforming service delivery by reinforcing a primary health care-centred model that integrates family medicine, nursing and midwifery; and improving financial sustainability by supporting reforms that ensure the long-term viability of the national health system and reduce out-of-pocket payments for households. Overall, these reforms are expected to make the health system more coherent and easier to navigate, improve the quality and continuity of care, and ensure more equitable access to services, particularly for those who need them most. They will also support Ukraine’s progress towards a more modern health system aligned with European standards. “We are convinced that long-term recovery is not possible without strong, high-quality, person-centred health services that are accessible to everyone. Our partnership with WHO is designed to support deep and lasting systemic changes. Investments in human capital especially autonomous midwives, whose role for maternal, newborn and adolescent sexual and reproductive health cannot be understated, stronger governance, digital transformation and the financial sustainability of the health system are investments in Ukraine’s future. We are proud to support this process,” said Malin Perhult, the Head of the Ukraine Unit at Sida. Focus throughout implementation will be given to the most vulnerable population groups, including older people, women and children, and persons with disabilities, who have been affected by the war and face greater health-care needs. The initiative will be implemented in close cooperation with the Ministry of Health of Ukraine, the National Health Service of Ukraine, the Public Health Centre of Ukraine, regional authorities and international partners. This project will help Ukraine move towards a system where everyone can access the health care they need. It will strengthen primary care, make the health finance system more stable and predictable, and reduce the out-of-pocket costs that Ukrainians face when using health services. As a result, the Ukrainian health system will become more aligned with European standards and more sustainable in the long run.
‘Disgusting and vile’: Locals react to arrest of Tampa business owner on AI child porn charges
A Tampa business owner is behind bars facing more than 100 felony charges. He’s accused of making child pornography using Artificial Intelligence.
Billionaire tax, affordable housing: See the measures on California's November ballot
California voters will decide on 14 statewide policy proposals come November, from the controversial billionaire tax to an $11 billion affordable housing bond.
Lionel Richie postpones concerts after falling ill during tour opener
Lionel Richie is pausing his return to the stage after abruptly falling ill during the opening of his new tour.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Trump keeps turning Republican wins into loyalty tests
President Donald Trump’s moves on housing, FISA, Iran and Washington projects are creating new headaches for Republicans trying to show voters they can govern.
New science on algae die-offs is too late for the Reflecting Pool
Iron and hydrogen peroxide trigger cell death via ferroptosis, which cascades killer molecules through the population, causing mass die-offs of algae.
Notion killing Skiff-influenced email app since most users use AI agents instead
Notion is "going all in on using agents to run your inbox."
Trump’s politics of emergencies leaves GOP allies scrambling again
In upending plans to sign a bipartisan housing bill, the president illustrated one of his favored tactics: declaring a policy preference to be an emergency.
Graham Platner backs legal maneuver using Maine law to rein in political spending
Democratic U.S. Senate nominee Graham Platner wants to overturn the landmark U.S. Supreme Court ruling that enabled corporations and other outside groups to spend unlimited money on elections by any means possible. He supports a constitutional amendment and ethics rules on the high court, which the Sullivan oyster farmer included in his latest policy rollout […]
Extreme heat and health: Policy guide reveals what communities need to know
Blistering temperatures exacerbated by high humidity are not just uncomfortable but dangerous. Across Canada, and in communities throughout southwestern Ontario, rising temperatures are affecting people's ...
New Enhanced Services Pilot Brings Home Health Aides to New Yorkers in Their New Homes
New York, NY – NYC Health + Hospitals’ Housing for Health initiative today announced Bridge to Care, a pilot program funded by The Leona M. and Harry B.
David P. O'Brien
About five years ago, David P. O'Brien had a comfortable position at Marsh & McLennan Cos., where he held the top post at the financial giant's Louisville, Ky., office. Despite the lofty rank, Mr. O'Brien found himself longing to be at a smaller company that had to work a little harder to land business. That desire led him away from Kentucky five years ago and to Cleveland, where he serves as executive vice president at business insurance agency Oswald Cos. "I left Marsh before it was en vogue," he said, referring to layoffs and defections at Marsh over the course of this year that followed accusations of bid rigging at the big firm. Above all, Mr. O'Brien, 38, wanted to work at a company that relied on its inventiveness, rather than its name, for business. He said he has found that at Oswald. "It causes you to be more creative, to be more resourceful," Mr. O'Brien said. For instance, an Oswald client seeking to do business internationally might be directed to the network of offices abroad run by competitors such as Marsh and Aon Risk Services Inc. "We're going to use whatever access into the market that makes the most sense for our clients," he said. Of course, using such a strategy can be dangerous for Oswald if its client decides to further a business relationship with one of the firms Oswald recommended. "That's the obvious question and why it's nontraditional," he said. "I think if we're good, and if we're bringing value to the client, then there's no risk. I'm not threatened by it." Imaginative business solutions of that type made his career move to Oswald from Marsh worthwhile. "It's very much a challenge," he said. "It helps you keep your edge. I'm all for the competition." John Jacunski, currently vice president and corporate controller at York, Pa., paper company PH Gladfelter Co., met Mr. O'Brien four years ago when Mr. Jacunski was at WCI Steel Inc. in Warren. So impressed was he with Mr. O'Brien's work for WCI that Mr. Jacunski has retained the Oswald executive at PH Gladfelter. "He's a young guy for the position he has, but he's done a great job for us," Mr. Jacunski said. Among his roles at Oswald, Mr. O'Brien leads the firm's client retention efforts and also serves as director of its property and casualty group. "You don't have the same human resources," he said of the job jump to Oswald. "You don't have, obviously, the safety net a big company has." But sometimes, it can be difficult to ascertain individual contributions when working at a big company. "I wanted to be able to see the end results of my work and my efforts," Mr. O'Brien said.
Trump to meet House speaker in attempt to break legislative gridlock
Trump suddenly scrapped the signing of a pivotal bipartisan housing bill yesterday, demanding the Senate pass his voter ID bill
AI for Small Business: The Quick-Win Approach
Voice of Business Blog Guest post from Greater Rochester Chamber member IT Insights of Rochester In 2025, 58% of small businesses report using generative AI tools, up from 40% in 2024 and 23% in 2023, according to the U.S. Chamber of Commerce. Adoption has grown quickly in just a few years and is now delivering…
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Mamdani and Hochul announce cash infusion for New York City Abortion Access Hub expansion
New York City and the Empire State are infusing hundreds of thousands of dollars into New York City Abortion Access Hub to expand its referral network
Scientists find thousands of earthquakes in a perfectly straight line in Alaska, revealing a hidden 'microplate'
Tiny earthquakes that emerge in a strikingly linear pattern revealed the Yakutat microplate, which may be focusing volcano and earthquake activity.
Bacteria-killing viruses redirect vaccine immunity to destroy cancer
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from vaccines
Politicians love 'affordability' rhetoric. But it hasn't offered path to urban prosperity in Kansas.
Wichita remains one of the most “affordable” regions to inhabit in the U.S. today, but that affordability has not served as as economic boon.
Scientists have just unlocked the secrets of an ancient scroll torched by Mount Vesuvius
After a centuries-long struggle, scholars managed to read five feet of text, using machine-learning methods they hope can unlock further discoveries.
CVS Health Foundation invests $1 million in Hartford nonprofits tackling community health needs
Local organizations receive Hometown Fund support to expand access to health care, food, housing and essential services
How architecture influences political activity
A new study in Ghana shows residents in semi-communal housing are more likely to vote, attend rallies, and take part in political campaigns, compared to people in more private forms of housing.
Sen. Van Hollen: Trump is saying he ‘doesn’t give a damn’ about people who can’t afford housing
Trump news at a glance: US president holds a rare bipartisan bill hostage
Trump says he’ll sign housing bill aimed at lowering costs only after Senate passes restrictive voting measure – key US politics stories from Wednesday 24 June at a glance
NATO’s Leader Makes His Case to Trump for Preserving the Alliance
Using charts, Secretary General Mark Rutte appeared to defuse the president’s anger by showing that European countries were “equalizing” defense spending with the U.S.
Country singer Bailey Zimmerman apologizes for canceled concert, charges dropped
Charges against Bailey Zimmerman have been dropped after prosecutors initially accused the country music star of causing $16,000 worth of damage to a New Mexico hotel room and canceling a
iOS 27 Home App: 10+ New HomeKit Features
Apple updated the Home app with some useful new features that rely on Apple Intelligence. The updates improve the way HomeKit Secure Video cameras work on Apple's HomeKit platform. Apple Intelligence Summaries The Home app generates written summaries for motion alerts and what's detected, using AI to determine what's been recorded.
By Refusing to Sign a Bipartisan Housing Bill, Trump Made It Clear That He Doesn’t Care About Everyday Americans
What’s the president’s priority instead? Passing his voter-suppressing SAVE Act to keep his cronies in power.
A tale of two Democratic parties: From the Politics Desk
Plus, Trump slams the brakes on a bipartisan housing bill.
Trump berates Senate Republicans over Iran war vote, calls off bill signing
Trump canceled a scheduled signing ceremony on a housing bill that passed both chambers overwhelmingly this week
How Brexit broke British politics
Brexit has had a lasting impact on British politics, causing a decade of turmoil and division, and resulting in the resignation of Prime Minister Keir Starmer after two years of economic stagnation and a divided electorate.
U.S. health spending rose sharply in 2025, thanks to GLP-1 use and more care
People are getting more care and using lots of GLP-1 drugs, fueling a sharp increase in health care spending.
Trump abruptly cancels signing housing bill, blindsiding Republicans
Trump is pressuring senators to focus on his proof-of-citizenship voting bill even though it doesn't have the votes to pass
New exhibit housing Endeavour Space Shuttle set to open at California Science Center in November
The Endeavour Space Shuttle will be housed in the newly built Samuel Oschin Shuttle Gallery.
Trump’s stunt on the housing bill seems like a very bad idea
President Donald Trump is a familiar legislative arsonist. He’ll often throw curveballs at the last minute that give congressional leaders fits – especially in his own party.
Trump says he won't sign major housing bill until Congress passes SAVE Act
The president's announcement came at an awkward time for House Republican leadership, coming just as they were speaking at a press conference about the importance of the bill in addressing affordability.
Trump refuses to sign landmark housing bill, demanding Congress pass voter ID law
Trump demanded that Congress pass the SAVE America Act, the proof-of-citizenship voting bill, before he would consider the housing legislation.
Trump abruptly cancels signing housing bill, blindsiding Republicans
Trump is pressuring senators to focus on his proof-of-citizenship voting bill even though it doesn't have the votes to pass
Trump abruptly cancels signing housing bill, blindsiding Republicans
Trump is pressuring senators to focus on his proof-of-citizenship voting bill even though it doesn't have the votes to pass
Trump cancels housing bill signing, pressures Congress to pass voter ID law
The bill was supposed to have been signed Wednesday at the Capitol
Trump cancels housing bill signing, pressures Congress to pass voter ID law
The bill was supposed to have been signed Wednesday at the Capitol
Trump abruptly cancels signing of bipartisan bill on affordable housing
The president posted on social media that the signing was off until the Senate passes his election integrity bill. It is unclear whether he intends to kill the housing bill.
Trump suddenly refuses to sign landmark housing bill, citing his stalled elections legislation
Trump cancels plan to sign major housing bill as he fights with Congress over the SAVE Act
Just hours before heading to Capitol Hill, Trump called the big, bipartisan housing bill Republicans hope to run on in the fall “of minor importance.”
Survey finds 3 in 10 adults using social media, AI for health information and advice
Results from a KFF poll published June 17 found that 31% of adults use social media at least monthly to seek health information and advice, similar to 29% who said they use artificial intelligence for the same purposes.
Trump to sign sweeping bipartisan housing affordability bill into law at Capitol
FSU computational scientist helps advance targeted drug-delivery systems using coding, modeling
A Florida State University computational scientist is paving the way for future medical breakthroughs by developing mathematical models and simulations to
This startup is using AI to close gaps in women’s healthcare
Xella Health’s precision health platform combines biomarker testing, clinical guidance, and AI analysis to help women get earlier answers about hard-to-diagnose conditions.
Prime Day 2026: Top Savings on Anker, Beats, TVs, and More Accessories
Earlier this week we highlighted some of the best Apple-related product discounts that you can find on Amazon during Prime Day, and now we're focusing on third-party accessory markdowns during the event. In this article you'll find all the best accessories for charging, smart homes, smartphones, and more. Note: MacRumors is an affiliate partner with some of these vendors. When you click a link and make a purchase, we may receive a small payment, which helps us keep the site running.
Business Transformations Are Failing Workers. Here's What Leaders Are Missing
Businesses are experiencing organizational change faster than employees can absorb it. Discover how companies can manage business transformation without causing burnout.
House gives final approval to landmark housing bill aimed at lowering costs
The legislation represents one of the most sweeping efforts in decades to increase the supply of housing and bring down prices.
Scientists discover hidden “footprints of death” that may help viruses spread
Scientists have uncovered a surprising new twist in what happens when cells die. As dying cells break apart, they leave behind tiny “footprints of death” packed with newly discovered particles that help guide the immune system to clean up the remains. But researchers found that influenza viruses can exploit this process, hiding inside these microscopic packages and potentially using them to spread to nearby cells.
How wearable tech aims to innovate women's health care
Clair Health co-founder and CTO (Chief Technology Officer) Abhinav Agarwal comes on Asking for a Trend to explain how the company is using AI models in its hormone monitoring device and how new doctors, specifically OBGYNs, can use it to learn more.
Science in Seconds: Improving GLP-1
A UConn Health researcher explains how her lab is focusing on how GLP-1 medications affect the brain and how they can be improved for the future
Live updates: Progressives score wins in New York; Trump to sign housing bill
Get live updates and the latest news as progressives score election victories in New York and Trump signs a housing affordability bill.
Helping people stay in treatment starts with the basics
SouthLight's Social Determinants of Health team helps patients connect to housing, transportation and other resources to support recovery.
Science Decoupling Hurts Human Progress
Science magazine has reported that in May, several members of the U.S. Congress introduced the Securing Innovation and Research from Adversaries (SIRA) Act, a bill that would prohibit U.S. researchers from using federal funds to collaborate with 'blacklisted' Chinese entities. These include Chinese institutions and individuals. Joint research projects, co-authored papers, data sharing, personnel exchanges, and even the co-supervision of students would all be prohibited.
Early humans were bringing fire into caves 1.8 million years ago
A new study suggests early humans were using fire in South Africa’s Wonderwerk Cave as far back as 1.79 million years ago. Researchers found burned bones deep inside the cave, where natural wildfires could not have reached, indicating that fire was likely carried in and maintained by human ancestors. The discovery pushes back the timeline for fire use and reveals surprisingly sophisticated behavior long before humans could create fire on demand.
House gives final approval to bipartisan housing bill aimed at lowering costs
Lawmakers in both parties are eager to show progress on affordability issues ahead of this year’s midterm elections
Family says SoCal police fatally shot teen during mental health crisis
Family files a claim against the city of Santa Ana, saying police fatally shot teen during mental health crisis without using non-lethal alternatives
People on GLP-1 medications are exercising less
A new study found that people using weight-loss drugs are doing less exercise, despite feeling healthier. Here's how muscle mass and bone density are affected.
Landmark housing bill advances in Congress with bipartisan support
Measures to provide federal funding for housing production in big cities could be particularly significant to California.
Hot chicken is OK, but soda isn’t? Battle over SNAP scrambles red-blue politics.
Both parties have been enacting state-level bans on using SNAP benefits for soda and candy. On Monday, a federal judge said the new rules violate federal laws governing the food program.
Science Will Not Save the Abortion Pill : The Hastings Center for Bioethics
The facts are not enough. In addition to using evidence, people who support the legal right to abortion must make the moral case for it.
It Ain’t Just Sports: CPR, tennis & a second chance with Adrian Murray
In this episode: We sit down with Adrian Murray, co-founder of T.R.I.N.I.T.Y Tennis, to talk about purpose, perseverance, and using tennis to promote heart health and life-saving skills.
Texas doctor charged in $89M fraud case as administration pushes health care crackdown
The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing insurers for medically unnecessary cardiovascular screening tests.
Texas doctor charged in $89M fraud case as administration pushes healthcare crackdown
The Justice Department says it has charged a Texas doctor in an $89 million healthcare fraud scheme, accusing him of billing insurers for medically unnecessary cardiovascular screening tests for college student-athletes and then rubber-stamping the res...
Senate passes bipartisan housing bill
This is the “biggest housing bill in more than 30 years,” said Sen. Elizabeth Warren (D-Mass.)
Scientists create optical skyrmions using a two-century-old light phenomenon
Nanyang Technological University, Singapore (NTU Singapore) scientists have used a classic optical phenomenon known as the Poisson spot to create stable patterns of light called optical skyrmions, which ...
"The 'AI Stigma' is real and severely punishes developers": A new study shows how much using AI in games hurts sales, and the numbers are hard to believe
Amateur developers might be able to make a quick buck, but established studios are seeing serious declines when using AI during development.
Listening for quantum oscillations in the Kondo insulator YbB12
Magnetic quantum oscillations have been unexpectedly observed in insulators, where freely moving charge carriers are not expected to exist. A joint study by researchers from Tokyo University of Science, The University of Tokyo, and Kobe University investigated this puzzling behavior in the Kondo insulator YbB12 using ultrasound. While no oscillations were detected in the insulating state, clear signals emerged after the material became metallic, offering new insight into unusual quantum behavior in next-generation materials.
Senate passes a bipartisan housing bill aimed at increasing supply
The legislation bans corporate investors from buying single-family homes